Blood marker determines who will respond to colorectal cancer drug

Posted by on May 13, 2016 12:31 pm
Categories: health

Cancer researchers have identified a marker that shows up in a blood test that determines which patients with colorectal cancer that has spread would benefit from receiving the drug cetuximab.

Leave a Reply

Your email address will not be published. Required fields are marked *